James Del Rosso - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock James Del Rosso's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
James Del Rosso
Verified
Host, Derms and Conditions
Las Vegas
Beats
Lgbt Health , Immigration, Health , World Music, Latino Community , Lgbt Issues, Middle East, Iran , Refugees
Content
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials
By Neal Bhatia, James Del Rosso, Linda Gold| JAMA (The Journal of the American Medical Association) Verified Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials Key PointsQuestion What is the efficacy and safety of DFD-29, 40 mg, a low-dose oral minocycline hydrochloride formulation, in moderate to severe rosacea compared with doxycycline, 40 mg, and placebo?
By Mona Shahriari, James Del Rosso| HCP Live Verified In the latest episode of The Medical Sisterhood, host Mona Shahriari, MD, an assistant clinical professor of dermatology at the Yale University School of Medicine and the associate director of clinical trials at Central Connecticut Dermatology Research, spoke alongside James Q.
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials
By Neal Bhatia, James Del Rosso, Linda Gold| JAMA (The Journal of the American Medical Association) Verified Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials Key PointsQuestion What is the efficacy and safety of DFD-29, 40 mg, a low-dose oral minocycline hydrochloride formulation, in moderate to severe rosacea compared with doxycycline, 40 mg, and placebo?
Company Info
Derms and Conditions